LGL leukemia patients are also characterized by increased IL-6 levels, mainly caused by persistent STAT3 stimulation, and therefore, the inhibition of IL-6 signaling leads to a decrease in phosphorylated STAT3, thereby reducing LGL leukemic cell survival [66,67]. The gene discussed is STAT3; the disease is T-cell large granular lymphocyte leukemia.